Fig. 3From: LncRNA MSTO2P promotes colorectal cancer progression through epigenetically silencing CDKN1A mediated by EZH2Inhibition of MSTO2P promotes cell cycle arrest and cell apoptosis. A, B Flow cytometry assay showed that the proportion of HT-29 and SW480 cells at the G0/G1 phase was elevated by si-MSTO2P. C, D Flow cytometry assay demonstrated that si-MSTO2P enhanced cell apoptosis. *p<0.05, **p<0.01, and ***p<0.001Back to article page